Compare Unichem Lab with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB CIPLA UNICHEM LAB/
CIPLA
 
P/E (TTM) x 89.0 28.9 307.7% View Chart
P/BV x 0.7 4.0 18.1% View Chart
Dividend Yield % 1.5 0.5 276.6%  

Financials

 UNICHEM LAB   CIPLA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-21
CIPLA
Mar-21
UNICHEM LAB/
CIPLA
5-Yr Chart
Click to enlarge
High Rs360879 41.0%   
Low Rs122411 29.6%   
Sales per share (Unadj.) Rs175.4237.6 73.8%  
Earnings per share (Unadj.) Rs4.929.8 16.5%  
Cash flow per share (Unadj.) Rs16.942.2 40.0%  
Dividends per share (Unadj.) Rs4.005.00 80.0%  
Avg Dividend yield %1.70.8 214.1%  
Book value per share (Unadj.) Rs362.0226.7 159.7%  
Shares outstanding (eoy) m70.41806.46 8.7%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.42.7 50.6%   
Avg P/E ratio x48.921.6 225.9%  
P/CF ratio (eoy) x14.215.3 93.3%  
Price / Book Value ratio x0.72.8 23.4%  
Dividend payout %81.216.8 483.8%   
Avg Mkt Cap Rs m16,954519,826 3.3%   
No. of employees `000NANA-   
Total wages/salary Rs m3,07032,518 9.4%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m12,351191,596 6.4%  
Other income Rs m5022,698 18.6%   
Total revenues Rs m12,853194,294 6.6%   
Gross profit Rs m91141,841 2.2%  
Depreciation Rs m84410,031 8.4%   
Interest Rs m511,607 3.2%   
Profit before tax Rs m51832,901 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1728,888 1.9%   
Profit after tax Rs m34724,013 1.4%  
Gross profit margin %7.421.8 33.8%  
Effective tax rate %33.127.0 122.5%   
Net profit margin %2.812.5 22.4%  
BALANCE SHEET DATA
Current assets Rs m13,773132,095 10.4%   
Current liabilities Rs m5,05845,916 11.0%   
Net working cap to sales %70.645.0 156.9%  
Current ratio x2.72.9 94.7%  
Inventory Days Days15568 228.4%  
Debtors Days Days7407 11,266.9%  
Net fixed assets Rs m17,344116,277 14.9%   
Share capital Rs m1411,613 8.7%   
"Free" reserves Rs m25,350181,232 14.0%   
Net worth Rs m25,491182,844 13.9%   
Long term debt Rs m012,028 0.0%   
Total assets Rs m31,118248,372 12.5%  
Interest coverage x11.121.5 51.8%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.40.8 51.5%   
Return on assets %1.310.3 12.4%  
Return on equity %1.413.1 10.4%  
Return on capital %2.217.7 12.6%  
Exports to sales %82.831.3 264.5%   
Imports to sales %14.410.9 132.1%   
Exports (fob) Rs m10,22459,951 17.1%   
Imports (cif) Rs m1,78020,911 8.5%   
Fx inflow Rs m10,22468,051 15.0%   
Fx outflow Rs m1,78020,911 8.5%   
Net fx Rs m8,44447,140 17.9%   
CASH FLOW
From Operations Rs m33137,552 0.9%  
From Investments Rs m-736-23,872 3.1%  
From Financial Activity Rs m-1,212-13,299 9.1%  
Net Cashflow Rs m-1,541509 -302.6%  

Share Holding

Indian Promoters % 50.9 14.9 343.0%  
Foreign collaborators % 0.0 22.4 -  
Indian inst/Mut Fund % 10.6 37.5 28.3%  
FIIs % 1.5 22.3 6.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.1 62.7 78.2%  
Shareholders   33,892 208,128 16.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CHANDRA BHAGAT PHARMA  BAFNA PHARMA  TORRENT PHARMA  EMMESSAR CHM  AUROBINDO PHARMA  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (3QFY21); Net Profit Up 112.8% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, CIPLA has posted a net profit of Rs 8 bn (up 112.8% YoY). Sales on the other hand came in at Rs 52 bn (up 18.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA 2019-20 Annual Report Analysis (Annual Result Update)

Nov 4, 2020 | Updated on Nov 4, 2020

Here's an analysis of the annual report of CIPLA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CIPLA Announces Quarterly Results (1QFY21); Net Profit Up 21.4% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, CIPLA has posted a net profit of Rs 6 bn (up 21.4% YoY). Sales on the other hand came in at Rs 43 bn (up 7.2% YoY). Read on for a complete analysis of CIPLA's quarterly results.

CIPLA Announces Quarterly Results (4QFY20); Net Profit Down 35.1% (Quarterly Result Update)

May 19, 2020 | Updated on May 19, 2020

For the quarter ended March 2020, CIPLA has posted a net profit of Rs 2 bn (down 35.1% YoY). Sales on the other hand came in at Rs 44 bn (down 0.6% YoY). Read on for a complete analysis of CIPLA's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 14, 2021 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - ISHITA DRUGS COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS